Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 3
2013 1
2014 4
2016 3
2017 2
2018 1
2019 2
2021 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H; LoVAS Collaborators. Furuta S, et al. JAMA. 2021 Jun 1;325(21):2178-2187. doi: 10.1001/jama.2021.6615. JAMA. 2021. PMID: 34061144 Free PMC article. Clinical Trial.
Sarcoidosis Presenting Addison's Disease.
Takahashi K, Kagami S, Kawashima H, Kashiwakuma D, Suzuki Y, Iwamoto I. Takahashi K, et al. Among authors: kashiwakuma d. Intern Med. 2016;55(9):1223-8. doi: 10.2169/internalmedicine.55.5392. Epub 2016 May 1. Intern Med. 2016. PMID: 27150885 Free article.
Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial.
Furuta S, Sugiyama T, Umibe T, Kaneko Y, Amano K, Kurasawa K, Nakagomi D, Hiraguri M, Hanaoka H, Sato Y, Ikeda K, Nakajima H; LoVAS Trial study investigators. Furuta S, et al. BMJ Open. 2017 Dec 14;7(12):e018748. doi: 10.1136/bmjopen-2017-018748. BMJ Open. 2017. PMID: 29247107 Free PMC article. Clinical Trial.
Development and characterization of IL-21-producing CD4+ T cells.
Suto A, Kashiwakuma D, Kagami S, Hirose K, Watanabe N, Yokote K, Saito Y, Nakayama T, Grusby MJ, Iwamoto I, Nakajima H. Suto A, et al. Among authors: kashiwakuma d. J Exp Med. 2008 Jun 9;205(6):1369-79. doi: 10.1084/jem.20072057. Epub 2008 May 12. J Exp Med. 2008. PMID: 18474630 Free PMC article.
Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan.
Furuta S, Chaudhry AN, Hamano Y, Fujimoto S, Nagafuchi H, Makino H, Matsuo S, Ozaki S, Endo T, Muso E, Ito C, Kusano E, Yamagata M, Ikeda K, Kashiwakuma D, Iwamoto I, Westman K, Jayne D. Furuta S, et al. Among authors: kashiwakuma d. J Rheumatol. 2014 Feb;41(2):325-33. doi: 10.3899/jrheum.130602. Epub 2014 Jan 15. J Rheumatol. 2014. PMID: 24429174
Role of Th2 cells in IgG4-related lacrimal gland enlargement.
Kanari H, Kagami S, Kashiwakuma D, Oya Y, Furuta S, Ikeda K, Suto A, Suzuki K, Hirose K, Watanabe N, Okamoto Y, Yamamoto S, Iwamoto I, Nakajima H. Kanari H, et al. Among authors: kashiwakuma d. Int Arch Allergy Immunol. 2010;152 Suppl 1:47-53. doi: 10.1159/000312125. Epub 2010 Jun 4. Int Arch Allergy Immunol. 2010. PMID: 20523063
Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3.
Tanaka S, Suto A, Iwamoto T, Kashiwakuma D, Kagami S, Suzuki K, Takatori H, Tamachi T, Hirose K, Onodera A, Suzuki J, Ohara O, Yamashita M, Nakayama T, Nakajima H. Tanaka S, et al. Among authors: kashiwakuma d. J Exp Med. 2014 Aug 25;211(9):1857-74. doi: 10.1084/jem.20130791. Epub 2014 Jul 29. J Exp Med. 2014. PMID: 25073789 Free PMC article.
17 results